This episode currently has no reviews.
Submit ReviewShares of Eli Lilly hit an intraday record after the company announced a website that would allow patients to buy weight-loss drug Zepbound directly from the company. Could this throw a wrench in how the pharma industry does business? Plus Gene Munster is out with his predictions for 2024, and one includes Apple adding Peloton to its portfolio.
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review